SANTA CLARA, California, Feb. 27, 2015 /PRNewswire/ -- Finesse expands office in Leicester, United Kingdom
Finesse Solutions announced the expansion of its operations in Leicester, England. The opening is planned for mid-March and access for customers is expected shortly afterward.
With easy access from the A-563, and located adjacent to the current office, the new premises will double the footprint occupied by the Finesse automation engineering team and allow Finesse to bring on more service personnel. The new building provides additional offices, a training room, and a test/demonstration laboratory.
Dr. Barbara Paldus, CEO of Finesse Solutions, stated, "We are pleased to announce that our new engineering and service center in Leicester is doubling in size and will allow us to provide our European customers with local support and training."
The new facility will enable Finesse staff to assist customers in finding solutions to processing challenges. It will also serve as a demonstration and training center offering customers a hands-on experience to fully explore the Finesse offering.
The Finesse portfolio of control, automation and single-use solutions continues to expand with new products ranging from single-use 3L SmartVessels for R&D to its new SmartFactory enterprise solution. With the new customer service center the Finesse team in the United Kingdom is looking forward to helping customers significantly enhance the development of new health care solutions.
About Finesse Solutions, Inc
Finesse Solutions provides flexible hardware and software automation which allows for unmatched customizable bioprocessing. We are a research based, Silicon Valley company who believes in empowering our clients with innovative single-use sensors, bioreactors, controllers and software. Our SmartParts are the foundation of a Finesse solution using technologies from inside and outside of the biopharmaceutical industry. In addition to our own products, we are the only supplier with integration expertise offering clients the independence to select any preferred supplier of key unit operations from upstream to downstream. Whether it's a stand-alone, single-use bioreactor for research and development or a fully integrated Smartfactory in cGMP manufacturing, we have a bioprocess solution for our customers.
For more information, please visit us at www.finesse.com.
.jpg)
